1-5 of 5
Marie-Elisabeth Goebeler
Close
Sort by
Journal Articles

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Andreas Viardot, Marie-Elisabeth Goebeler, Georg Hess, Svenja Neumann, Michael Pfreundschuh, Nicole Adrian, Florian Zettl, Martin Libicher, Cyrus Sayehli, Julia Stieglmaier, Alicia Zhang, Dirk Nagorsen, Ralf C. Bargou
Journal: Blood
Blood (2016) 127 (11): 1410–1416.
https://doi.org/10.1182/blood-2015-06-651380
Published: 2016
Includes: Supplemental data
Journal Articles

Long-Term Survival in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Achieved Minimal Residual Disease (MRD) Response Following Anti-CD19 BiTE ® Blinatumomab

Gerhard Zugmaier, Nicola Goekbuget, Andreas Viardot, Matthias Stelljes, Svenja Neumann, Heinz A. Horst, Albrecht Reichle, Reinhard Marks, Christoph Faul, Monika Brueggemann, Chris Holland, Margit Schmidt, Noemi Mergen, Marie-Elisabeth Goebeler, Hermann Einsele, Ralf C. Bargou, Max S. Topp
Journal: Blood
Blood (2014) 124 (21): 2287.
https://doi.org/10.1182/blood.V124.21.2287.2287
Published: 2014
Journal Articles

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

Brief Report
Max S. Topp, Nicola Gökbuget, Gerhard Zugmaier, Evelyn Degenhard, Marie-Elisabeth Goebeler, Matthias Klinger, Svenja A. Neumann, Heinz A. Horst, Thorsten Raff, Andreas Viardot, Matthias Stelljes, Markus Schaich, Rudolf Köhne-Volland, Monika Brüggemann, Oliver G. Ottmann, Thomas Burmeister, Patrick A. Baeuerle, Dirk Nagorsen, Margit Schmidt, Hermann Einsele, Gert Riethmüller, Michael Kneba, Dieter Hoelzer, Peter Kufer, Ralf C. Bargou
Journal: Blood
Blood (2012) 120 (26): 5185–5187.
https://doi.org/10.1182/blood-2012-07-441030
Published: 2012
Journal Articles

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate and Prolongs Overall Survival in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)

Max S. Topp, Nicola Goekbuget, MD, Gerhard Zugmaier, Andreas Viardot, MD, Matthias Stelljes, MD, Svenja Neumann, Heinz A. Horst, Albrecht Reichle, Reinhard Marks, Christoph Faul, MD, Monika Brueggemann, Matthias Ritgen, Petra Klappers, Noemi Mergen, Marie-Elisabeth Goebeler, Hermann Einsele, Ralf Bargou
Journal: Blood
Blood (2012) 120 (21): 670.
https://doi.org/10.1182/blood.V120.21.670.670
Published: 2012
Journal Articles

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial

Max S. Topp, MD, Nicola Goekbuget, MD, Gerhard Zugmaier, MD, Andreas Viardot, MD, Matthias Stelljes, Svenja Neumann, MD, Heinz A. Horst, MD, Albrecht Reichle, MD, Reinhard E Marks, MD, Monika Brueggemann, MD, Matthias Ritgen, MD, Petra Klappers, Noemi Mergen, MD, Marie-Elisabeth Goebeler, MD, Hermann Einsele, Dieter Hoelzer, MD, Ralf Bargou, MD
Journal: Blood
Blood (2011) 118 (21): 252.
https://doi.org/10.1182/blood.V118.21.252.252
Published: 2011